Literature DB >> 12889214

Assessment of skin, joint, tendon and muscle involvement.

A Akesson1, G Fiori, T Krieg, F H van den Hoogen, J R Seibold.   

Abstract

This report makes recommendations for standardized techniques of data gathering and collection regarding: 1) skin involvement 2) joint and tendon involvement, and 3) involvement of the skeletal muscles. The recommendations in this report derive from a critical review of the available literature and group discussion. Committee recommendations are considered appropriate for descriptive clinical investigation, translational studies and as standards for clinical practice. Skin involvement should be assessed using the modified Rodnan skin score. Joint involvement, when symmetric synovitis is present, could be best assessed by the DAS-28 as is utilized in rheumatoid arthritis. Clinical assessment should include a routinized evaluation for the presence and number of palpable tendon friction rubs. Muscle involvement should be screened for by performance of the serum creatine phosphokinase assay and assessment of proximal weakness. More specific testing including EMG, magnetic resonance imaging and muscle biopsy should be employed in those patients with clinically significant myopathy only.

Entities:  

Mesh:

Year:  2003        PMID: 12889214

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  20 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

2.  Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.

Authors:  Raffaele De Palma; Francesco Del Galdo; Salvatore Lupoli; Paolo Altucci; Gianfranco Abbate; Gabriele Valentini
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

3.  Anti-cyclic citrullinated peptide antibodies in scleroderma patients.

Authors:  M Polimeni; D Feniman; T S Skare; Renato M Nisihara
Journal:  Clin Rheumatol       Date:  2012-01-04       Impact factor: 2.980

4.  Coexistence of systemic sclerosis with other autoimmune diseases.

Authors:  Paola Caramaschi; Domenico Biasi; Alessandro Volpe; Antonio Carletto; Melissa Cecchetto; Lisa Maria Bambara
Journal:  Rheumatol Int       Date:  2006-09-19       Impact factor: 2.631

5.  Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Daniele Prati; Giovanni Barausse; Ilaria Tinazzi; Viviana Ravagnani; Silvia Confente; Domenico Biasi
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

6.  Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Giovanni Barausse; Davide Gatti; Marcello Ferrari; Sara Pieropan; Dania Sabbagh; Silvano Adami
Journal:  Clin Rheumatol       Date:  2013-09-20       Impact factor: 2.980

7.  Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial.

Authors:  Puja P Khanna; Daniel E Furst; Philip J Clements; Paul Maranian; Lilavati Indulkar; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2010-02-09       Impact factor: 7.580

8.  Cyclophosphamide treatment improves microvessel damage in systemic sclerosis.

Authors:  Paola Caramaschi; Alessandro Volpe; Sara Pieropan; Ilaria Tinazzi; Helal Mahamid; Lisa Maria Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

9.  The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study.

Authors:  Giovanni La Montagna; Antonio Sodano; Vittorio Capurro; Domenico Malesci; Gabriele Valentini
Journal:  Skeletal Radiol       Date:  2004-09-17       Impact factor: 2.199

10.  [Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)].

Authors:  N Hunzelmann; E Genth; T Krieg; M Meurer; I Melchers; P Moinzadeh; C Pfeiffer; G Riemekasten; E Schulze-Lohoff; C Sunderkoetter; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.